Since metabolic reprogramming is a hallmark of malignancy and crucial for supporting the heightened proliferation of tumor cells [31], our results imply that TRAF6 loss in leukemia cells induces metabolic alterations, contributing to their inhibited growth capacity. The gene discussed is TRAF6; the disease is neoplasm.